Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb;35(1):99-115.
doi: 10.1016/j.ccl.2016.08.010.

Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries

Affiliations
Review

Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries

Rajesh Vedanthan et al. Cardiol Clin. 2017 Feb.

Abstract

Elevated blood pressure, a major risk factor for ischemic heart disease, heart failure, and stroke, is the leading global risk for mortality. Treatment and control rates are very low in low- and middle-income countries. There is an urgent need to address this problem. The Global Alliance for Chronic Diseases sponsored research projects focus on controlling hypertension, including community engagement, salt reduction, salt substitution, task redistribution, mHealth, and fixed-dose combination therapies. This paper reviews the rationale for each approach and summarizes the experience of some of the research teams. The studies demonstrate innovative and practical methods for improving hypertension control.

Keywords: Community engagement; Hypertension; Low- and middle-income countries; Polypill; Salt reduction; Salt substitution; Task redistribution; mHealth.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Community engagement activities undertaken within GACD Projects. Participation activities denote the least level of engagement while empowerment activities denote the greatest level of engagement.
Figure 2
Figure 2
Framework for salt reduction strategies, including context, activities, outputs, and anticipated outcomes.
Figure 3
Figure 3
Launching a salt substitute to reduce blood pressure at the population level in Peru, divided into two phases.
Figure 4
Figure 4
The process of task-redistribution for the management of hypertension adapted from the WHO’s recommendations on task-shifting. From World Health Organization, PEPFAR, UNAIDS. Task shifting: rational redistribution of tasks among health workforce teams : global recommendations and guidelines. http://www.who.int/healthsystems/TTR-TaskShifting.pdf, 2016, with permission.
Figure 5
Figure 5
Proportion of participants adherent to combination therapy at end of study in patients either with established CVD or at high calculated risk. Adherence is defined as taking antiplatelet, statin and ≥ 2 BP-lowering drugs at least 4 days of the last 7 at end of study in UMPIRE, Kanyini-GAP and IMPACT. Adherence in the FOCUS trial was defined as pill count between 80 and 110% at end of study plus a score of 20/20 on the Morisky-Green questionnaire. Data from references , , , .
Figure 6
Figure 6
Schematic illustrating the potential for mHealth to connect clinicians, community health workers (CHWs), and patients. Blue arrows indicate direct interactions among individuals. Red arrows indicate interactions that are facilitated by mHealth.

References

    1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–2260. - PMC - PubMed
    1. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913. - PubMed
    1. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA : the journal of the American Medical Association. 2013;310(9):959–968. - PubMed
    1. [Accessed 5/20/2016];Disease GAfC. http://www.gacd.org/about/history/whoweare.
    1. Tobe W S, the Global Alliance for Chronic Diseases Hypertension Research Teams With the World Hypertension L. The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low- and Middle-Income Countries. The Journal of Clinical Hypertension. 2016 n/a-n/a. - PMC - PubMed

Substances